Search

everythinglearnresearchcommunity

for

Search:↓

Fetal-maternal stem cells in a mother's hair can help with tissue repair and regeneration long after childbirth.

Bacteria in our hair can affect its health and growth, and studying these bacteria could help us understand hair diseases better.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Finasteride affects frog testes by increasing testosterone, decreasing 5α-DHT, and impacting genes related to reproduction and other functions.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

Deleting the p63 gene in certain cells causes problems in thymus development and severe hair loss in mice.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.

Melanocytes are important for skin and hair color and protect the skin from UV damage.

Researchers found four genes that could help diagnose severe alopecia areata early.

The research reveals how early embryonic mouse skin develops from simple to complex structures, identifying various cell types and their roles in this process.

AIDS may cause changes in the scalp that increase infection risk and hair loss.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Genes related to keratin, skin cell differentiation, and immune functions are key in hedgehog skin and spine development.

Vitiligo causes white skin patches and can lead to psychological stress.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

The document explains the genetic causes and characteristics of inherited hair disorders.

Pantethine may boost the immune system's ability to fight sarcoma.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

The document concludes that the skin is a complex organ providing protection, sensation, and healing, with challenges in treating conditions like itchiness.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Pica disorder in central Iraq is mainly found in females and is linked to low iron levels; treatment with iron improves most patients.